Literature DB >> 11934873

IFN-alpha enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells.

Thomas Luft1, Petra Luetjens, Hubertus Hochrein, Tracey Toy, Kelly-Anne Masterman, Mark Rizkalla, Charlie Maliszewski, Ken Shortman, Jonathan Cebon, Eugene Maraskovsky.   

Abstract

Type I IFN are immune modulatory cytokines that are secreted during early stages of infection. Type I IFN bridge the innate and the adaptive immune system in humans and mice. We compared the capacity of type I and II IFN to induce the functional maturation of monocyte-derived dendritic cells (MoDC). Extending our earlier observation that type I IFN promote DC maturation, we report that these cytokines also enhance DC differentiation by augmenting CD40 ligand (CD40L)-induced cytokine secretion by MoDC. Type I IFN alone were poor inducers of MoDC maturation as compared with other stimuli. They up-regulated the expression of HLA-DR, CD80, CD86, partially CCR7 but not CD83, partially reduced antigen-uptake function, increased the levels of IL-12p35 mRNA, and prolonged surface expression of peptide-MHC class I complexes for presentation to cytotoxic T lymphocytes, but did not induce migration towards CCL21 chemokine. However, type I IFN were potent co-factors for CD40L-mediated function. Here, they enhanced CD40L-mediated IL-6, IL-10 and IL-12p70 secretion. Furthermore, when combined with IL-1beta and/or IL-4, IFN-alpha2a type I IFN increased CD40L-mediated IL-12p70 production by 2- to 3-fold, and biased the IL-12 p40/p70 ratio towards the IFN-gamma inducing p70 heterodimer, this correlating with higher levels of IFN-gamma secretion by allogeneic T cell subsets and NK cells. Our results suggest that the rapid expression of CD40L, IFN and IL-1beta at sites of infection and inflammation can act in concert on immature DC, thereby linking innate and adaptive immune responses. In this way, type I IFN play a dual role as DC maturation factors and enhancers of CD40L-mediated DC activation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11934873     DOI: 10.1093/intimm/14.4.367

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  29 in total

1.  Proteasomal chymotrypsin-like peptidase activity is required for essential functions of human monocyte-derived dendritic cells.

Authors:  Cord Naujokat; Carsten Berges; Alexandra Höh; Hubert Wieczorek; Dominik Fuchs; Jörg Ovens; Marion Miltz; Mahmoud Sadeghi; Gerhard Opelz; Volker Daniel
Journal:  Immunology       Date:  2006-11-03       Impact factor: 7.397

2.  Interferon-alpha2a is sufficient for promoting dendritic cell immunogenicity.

Authors:  A Tamir; W J Jordan; M Ritter; N Habib; R I Lechler; G R Foster; G Lombardi
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

3.  Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists.

Authors:  Thanh-Nhan Nguyen-Pham; Mi-Seon Lim; Truc Anh Thi Nguyen; Youn-Kyung Lee; Chun-Ji Jin; Hyun Ju Lee; Cheol Yi Hong; Jae-Sook Ahn; Deok-Hwan Yang; Yeo-Kyeoung Kim; Ik-Joo Chung; Byoung Chul Park; Hyeoung-Joon Kim; Je-Jung Lee
Journal:  Cell Mol Immunol       Date:  2011-03-21       Impact factor: 11.530

4.  Total chemical synthesis of human interferon alpha-2b via native chemical ligation.

Authors:  Jing Li; Clara Lehmann; Xishan Chen; Fabio Romerio; Wuyuan Lu
Journal:  J Pept Sci       Date:  2015-03-24       Impact factor: 1.905

5.  Type I IFN drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processing.

Authors:  Daimon P Simmons; Pamela A Wearsch; David H Canaday; Howard J Meyerson; Yi C Liu; Ying Wang; W Henry Boom; Clifford V Harding
Journal:  J Immunol       Date:  2012-02-27       Impact factor: 5.422

6.  Monocyte activation by interferon α is associated with failure to achieve a sustained virologic response after treatment for hepatitis C virus infection.

Authors:  Dennis J Hartigan-O'Connor; Din Lin; James C Ryan; Valentina A Shvachko; Myrna L Cozen; Mark R Segal; Norah A Terrault; Lewis L Lanier; M Michele Manos; Joseph M McCune
Journal:  J Infect Dis       Date:  2013-12-10       Impact factor: 5.226

7.  Nonstructural proteins 1 and 2 of respiratory syncytial virus suppress maturation of human dendritic cells.

Authors:  Shirin Munir; Cyril Le Nouen; Cindy Luongo; Ursula J Buchholz; Peter L Collins; Alexander Bukreyev
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

8.  Impact of alpha interferon and ribavirin on the function of maturing dendritic cells.

Authors:  Eleanor Barnes; Mariolina Salio; Vincenzo Cerundolo; Joanne Medlin; Shona Murphy; Geoffrey Dusheiko; Paul Klenerman
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

9.  Gene expression profiles identify inflammatory signatures in dendritic cells.

Authors:  Anna Torri; Ottavio Beretta; Anna Ranghetti; Francesca Granucci; Paola Ricciardi-Castagnoli; Maria Foti
Journal:  PLoS One       Date:  2010-02-24       Impact factor: 3.240

10.  An unusual case of Erdheim-Chester disease with features of Langerhans cell histiocytosis.

Authors:  Paul S Furmanczyk; James D Bruckner; Thurman Gillespy; Brian P Rubin
Journal:  Skeletal Radiol       Date:  2007-05-11       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.